Ophir Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36M Buy
1,264,809
+276,758
+28% +$6.02M 2.96% 15
2026
Q1
$17.2M Buy
988,051
+62,618
+7% +$1.19M 2% 22
2025
Q4
$17.4M Sell
925,433
-1,272,514
-58% -$21.3M 1.96% 26
2025
Q3
$32M Buy
2,197,947
+304,953
+16% +$4.35M 3.95% 12
2025
Q2
$24.3M Buy
1,892,994
+274,625
+17% +$4.88M 3.87% 13
2025
Q1
$28.7M Buy
+1,618,369
New +$34.9M 5.02% 5

Other funds holding CDNA

Ophir Asset Management's CDNA Position: Q2 2026 in Review

Ophir Asset Management increased its CareDx (CDNA) stake by 28% in Q2 2026, buying an estimated $6.02M and bringing the position to 1,264,809 shares worth $36M. The position accounts for 2.96% of the portfolio, ranked #15.

Ophir Asset Management first reported a position in CDNA in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Ophir Asset Management held 1,264,809 shares of CareDx worth $36M as of Q2 2026.
  • Ophir Asset Management bought 276,758 CareDx shares in Q2 2026, an estimated $6.02M.
  • CareDx made up 2.96% of Ophir Asset Management's portfolio in Q2 2026, its #15 holding.
  • Ophir Asset Management first reported a position in CareDx in Q1 2025 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Ophir Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.